Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'".
Dauby N, Hautekiet J, Catteau L, Montourcy M, Van Beckhoven D, Bottieau E, Goetghebeur E. Dauby N, et al. Among authors: catteau l. Int J Antimicrob Agents. 2021 Apr;57(4):106307. doi: 10.1016/j.ijantimicag.2021.106307. Epub 2021 Feb 17. Int J Antimicrob Agents. 2021. PMID: 33609720 Free PMC article. No abstract available.
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.
Catteau L, Dauby N, Montourcy M, Bottieau E, Hautekiet J, Goetghebeur E, van Ierssel S, Duysburgh E, Van Oyen H, Wyndham-Thomas C, Van Beckhoven D; Belgian Collaborative Group on COVID-19 Hospital Surveillance. Catteau L, et al. Int J Antimicrob Agents. 2020 Oct;56(4):106144. doi: 10.1016/j.ijantimicag.2020.106144. Epub 2020 Aug 24. Int J Antimicrob Agents. 2020. PMID: 32853673 Free PMC article.
Reply to 'Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality'.
Dauby N, Catteau L, Hautekiet J, Montourcy M, Bottieau E, Goetghebeur E, Van Beckhoven D. Dauby N, et al. Among authors: catteau l. Int J Antimicrob Agents. 2021 Feb;57(2):106261. doi: 10.1016/j.ijantimicag.2020.106261. Epub 2020 Dec 13. Int J Antimicrob Agents. 2021. PMID: 33321211 Free PMC article. No abstract available.
Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium.
Van Goethem N, Vandromme M, Van Oyen H, Haarhuis F, Brondeel R, Catteau L, André E, Cuypers L; Belgian Collaborative Group on COVID-19 Hospital surveillance; COVID-19 Genomics Belgium consortium; Blot K, Serrien B. Van Goethem N, et al. Among authors: catteau l. PLoS One. 2022 Jun 3;17(6):e0269138. doi: 10.1371/journal.pone.0269138. eCollection 2022. PLoS One. 2022. PMID: 35657787 Free PMC article.
COVID-19 Clusters in Belgian Nursing Homes: Impact of Facility Characteristics and Vaccination on Cluster Occurrence, Duration and Severity.
Dequeker S, Callies M, Catteau L, Int Panis L, Islamaj E, Klamer S, Latour K, Pauwels M, Vernemmen C, Mahieu R, Masson H, Savsin M, De Clercq E, Thomas M, Catry B, Vandael E. Dequeker S, et al. Among authors: catteau l. Viruses. 2023 Jan 13;15(1):232. doi: 10.3390/v15010232. Viruses. 2023. PMID: 36680272 Free PMC article.
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
Braeye T, Cornelissen L, Catteau L, Haarhuis F, Proesmans K, De Ridder K, Djiena A, Mahieu R, De Leeuw F, Dreuw A, Hammami N, Quoilin S, Van Oyen H, Wyndham-Thomas C, Van Cauteren D. Braeye T, et al. Among authors: catteau l. Vaccine. 2021 Sep 15;39(39):5456-5460. doi: 10.1016/j.vaccine.2021.08.060. Epub 2021 Aug 19. Vaccine. 2021. PMID: 34454789 Free PMC article.
30 results